Your browser doesn't support javascript.
loading
Single cell view of tumor microenvironment gradients in pleural mesothelioma.
Giotti, Bruno; Dolasia, Komal; Zhao, William; Cai, Peiwen; Sweeney, Robert; Merritt, Elliot; Kiner, Evgeny; Kim, Grace S; Bhagwat, Atharva; Nguyen, Thinh; Hegde, Samarth; Fitzgerald, Bailey G; Shroff, Sanjana; Dawson, Travis; Garcia-Barros, Monica; Abdul-Ghafar, Jamshid; Chen, Rachel; Gnjatic, Sacha; Soto, Alan; Brody, Rachel; Kim-Schulze, Seunghee; Chen, Zhihong; Beaumont, Kristin G; Merad, Miriam; Flores, Raja M; Sebra, Robert P; Horowitz, Amir; Marron, Thomas U; Tocheva, Anna; Wolf, Andrea; Tsankov, Alexander M.
Afiliação
  • Giotti B; Icahn School of Medicine at Mount Sinai, New York, NY, United States.
  • Dolasia K; Icahn School of Medicine at Mount Sinai, New York, NY, United States.
  • Zhao W; Icahn School of Medicine at Mount Sinai, New York, NY, United States.
  • Cai P; Icahn School of Medicine at Mount Sinai, New York, New York, United States.
  • Sweeney R; Icahn School of Medicine at Mount Sinai, New York, NY, United States.
  • Merritt E; Icahn School of Medicine at Mount Sinai, New York, NY, United States.
  • Kiner E; Immunai (United States), New York, NY, United States.
  • Kim GS; Icahn School of Medicine at Mount Sinai, New York, NY, United States.
  • Bhagwat A; Icahn School of Medicine at Mount Sinai, New York, NY, United States.
  • Nguyen T; Icahn School of Medicine at Mount Sinai, New York, NY, United States.
  • Hegde S; Icahn School of Medicine at Mount Sinai, New York, New York, United States.
  • Fitzgerald BG; Roswell Park Cancer Institute, New York, NY, United States.
  • Shroff S; Icahn School of Medicine at Mount Sinai, New York, NY, United States.
  • Dawson T; Icahn School of Medicine at Mount Sinai, New York, NY, United States.
  • Garcia-Barros M; Icahn School of Medicine at Mount Sinai, United States.
  • Abdul-Ghafar J; Icahn School of Medicine at Mount Sinai, New York, NY, United States.
  • Chen R; Icahn School of Medicine at Mount Sinai, New York, NY, United States.
  • Gnjatic S; Icahn School of Medicine at Mount Sinai, New York, NY, United States.
  • Soto A; Icahn School of Medicine at Mount Sinai, New York, United States.
  • Brody R; Icahn School of Medicine at Mount Sinai, New York, New York, United States.
  • Kim-Schulze S; Icahn School of Medicine at Mount Sinai, New York, NY, United States.
  • Chen Z; Icahn School of Medicine at Mount Sinai, New York, NY, United States.
  • Beaumont KG; Icahn School of Medicine at Mount Sinai, New York, New York, United States.
  • Merad M; Precision Immunology Institute, New York, NY, United States.
  • Flores RM; Icahn School of Medicine, Mount Sinai Health System, New York, NY, United States.
  • Sebra RP; Icahn School of Medicine at Mount Sinai, New York, NY, United States.
  • Horowitz A; Icahn School of Medicine at Mount Sinai, New York, United States.
  • Marron TU; Icahn School of Medicine at Mount Sinai, New York, NY, United States.
  • Tocheva A; Icahn School of Medicine at Mount Sinai, New York, NY, United States.
  • Wolf A; Icahn School of Medicine at Mount Sinai, New York, NY, United States.
  • Tsankov AM; Icahn School of Medicine at Mount Sinai, New York, NY, United States.
Cancer Discov ; 2024 Jul 05.
Article em En | MEDLINE | ID: mdl-38959428
ABSTRACT
Immunotherapies have shown great promise in pleural mesothelioma (PM), yet most patients still do not achieve significant clinical response, highlighting the importance of improving understanding of the tumor microenvironment (TME). Here, we utilized high-throughput, single-cell RNA-sequencing to de novo identify 54 expression programs and construct a comprehensive cellular catalogue of the PM TME. We found four cancer-intrinsic programs associated with poor disease outcome and a novel fetal-like, endothelial cell population that likely responds to VEGF signaling and promotes angiogenesis. Throughout cellular compartments, we observe substantial difference in the TME associated with a cancer-intrinsic sarcomatoid signature, including enrichment in fetal-like endothelial cells, CXCL9+ macrophages, cytotoxic, exhausted, and regulatory T cells, which we validated using imaging and bulk deconvolution analyses on independent cohorts. Finally, we show, both computationally and experimentally, that NKG2A-HLA-E interaction between NK and tumor cells represents an important new therapeutic axis in PM, especially for epithelioid cases.

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article